Deregulations in gut microbiota may play a role in vascular and bone disease in chronic
kidney disease (CKD). As glomerular filtration rate declines, the colon becomes more …

Background Biochemical markers of altered mineral metabolism have been associated with
increased mortality in end stage renal disease patients. Several studies have demonstrated …

Background and objectives: Coronary artery calcification (CAC) is highly prevalent among
patients with chronic kidney disease (CKD), and it has been described as a strong predictor …

Background Coronary artery calcification (CAC) is associated with cardiovascular mortality
in end-stage renal disease (ESRD) patients. The present study aimed to identify modifiable …

Parathyroidectomy (PTX) may cause low levels of PTH, leading to an excessive reduction of
bone turnover, which is associated with poor outcomes in dialysis patients, including …

Introduction Sclerostin has been reported to be a novel biomarker associated with the bone-
vascular axis. In this study, we determined the relationships between serum sclerostin and …

Background: The aim of this prospective cohort study was to evaluate the progression of
coronary artery calcification (CAC), and atherosclerosis in hemodialysis (HD) patients and to …

A doença renal crônica (DRC) afeta 5-10% da população mundial e sua incidência no
Brasil têm aumentado, devido ao número crescente de pacientes diagnosticados …

BACKGROUND: Patients on dialysis may have abnormal serum levels of Ca, P and
parathyroid hormone, with related bone diseases. This population has an increased risk of …

Backgrounds and Aims The presence and progression of vascular calcification have been
demonstrated as important risk factors for mortality in dialysis patients. However, since the …